UnitedHealth Group reported third-quarter earnings that exceeded analyst expectations, with adjusted earnings per share of $4.69 versus the expected $4.14, and revenue of $112.69 billion. The company raised its fiscal 2026 adjusted earnings forecast to at least $20.50 per share, up from the previous $19.50-$20 range, driven by investments in value-based care and artificial intelligence. Despite ongoing elevated medical costs, UnitedHealth is managing expenses by shrinking membership, exiting unprofitable contracts, and shifting patients to lower-cost care settings. These efforts, along with AI tools reducing administrative burdens on physicians, are expected to improve cost management and profitability through 2027.
UnitedHealth Group shares trade at USD 390.00 on Pluang as of Oct 13, 2026 17:12 WIB, up 3.03% for the day. The stock's market cap stands at $340.46 billion with a dividend yield of 2.45%. Buy orders dominate at 64%, reflecting investor interest during this earnings season.
UnitedHealth Group is set to report earnings on October 13, with options showing implied volatility twice the realized volatility, making options expensive. This creates opportunities for traders to use short premium strategies, such as selling Novem...
Johnson & Johnson and UnitedHealth Group both released their third-quarter 2026 earnings on the same morning, highlighting key trends in drug costs, insurance margins, and sector outlook. Johnson & Johnson showed steady revenue growth with strong per...
UnitedHealth Group is rated a conditional Buy as its profitability improves significantly despite flat revenue and shrinking membership. The company has exited unprofitable business lines, driving margin expansion. Its current valuation is below the ...
Humana's stock surged 16% after the company announced improved Medicare Advantage Star Ratings for 2027, with 95% of its members enrolled in plans rated four stars or higher. This improvement reflects better preventive care and earlier disease detect...
Halper Sadeh LLC is investigating whether certain UnitedHealth Group officers and directors violated their fiduciary duties to shareholders. Long-term shareholders of UnitedHealth stock may be eligible to seek corporate governance reforms, financial ...
